1. Comparison of the effect of prostacyclin (PGI2), PGE, and D2 on platelet aggregation in different species;Whittle;Prostaglandins,1978
2. Cardiovascular actions of prostacyclin (PGl2),a metabolite of arachidonic acid, which is syntheti^ed by blood vessels;Armstrong;Circ. Res.,1978
3. The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36374)-equipotent to PGI2 in vitro;Shror;Naunyn Schmiedebergs Arch. Pharmacol.,1981
4. Kawasaki, A., Katsube, N., Sakaguchi, K., Hiraku, S. and Tsuboshima, M.: Pharmacology of a new stable prostaglandin analogue. OP-41483,15-cyclopentyl-u-pentanor-5-E-metano-PGI2. The 5th International Conference on Prostaglandins (Florence), Abstract p. 313 (1982)
5. Inhibition of platelet aggregation and reversal of vasopressin-induced ECG changes by a carboprostacyclin analogue, ONO 41483, in primates;Adaikan;Prostaglandins, Leukotrienes Med.,1982